PEDIACARE CHILDREN'S ALLERGY OTC
Generic Name and Formulations:
Diphenhydramine HCl 12.5mg; per 5mL; liq; cherry-flavor, alcohol-free, contains sodium 14mg/5mL.
McNeil Consumer Healthcare
Indications for PEDIACARE CHILDREN'S ALLERGY:
Rhinorrhea, sneezing, allergy symptoms.
<4yrs: do not use. 4–5yrs: not recommended. 6–11yrs: 5mL every 4 hours; max 6 doses/24 hours.
Children <4yrs old. Concomitant other diphenhydramine products (including topicals). For use as a sedative hypnotic.
Glaucoma. GI or GU obstruction. Asthma. Lower respiratory disorders.
See Contraindications. Increased CNS effects with other CNS depressants.
Drowsiness, anticholinergic effects, excitability.
Liq—4oz (w. dosing cup)
Clinical Pain Advisor Articles
- Analyzing Coverage of Nonpharmacologic Treatments for Low Back Pain
- Smartphone App Helps Evaluate Catastrophizing in Chronic Pain
- Predicting the Magnitude of Placebo Analgesia in Chronic Pain
- Dsuvia Gains FDA Approval: We Want to Hear Your Thoughts
- Operant Learning May Provide More Benefits Than Energy Conservation in Fibromyalgia
- The Unintended Consequences of the CDC Opioid Guideline According to Pain Management Specialists
- Seven-Item Pain Intensity Measure Reliable in Individuals With Dementia
- Initial Consultation for Neck Pain May Reduce Opioid Consumption, Healthcare Utilization
- FDA-Approved Test Provides Pharmacogenetic Reports Directly to Consumers
- Set of Interventions May Effectively Reduce Opioid Overprescribing
- Methamphetamine Use on the Rise in Patients With Opioid Use Disorder
- Two Screening Tools May Accurately Predict Transition From Acute to Chronic Low Back Pain
- Dozens of Medical Groups Join Forces to Improve Diagnoses
- FDA Grants Non-Opioid Analgesic VVZ-149 Fast Track Status
- Little to No Association Found Between Physician Performance and Medical School Ranking